Waters Corporation $WAT Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH boosted its holdings in Waters Corporation (NYSE:WAT) by 21.4% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 96,097 shares of the medical instruments supplier’s stock after acquiring an additional 16,951 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Waters were worth $28,811,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC lifted its holdings in shares of Waters by 112.9% in the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after purchasing an additional 673 shares during the last quarter. Integrated Wealth Concepts LLC increased its position in Waters by 2.9% in the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after buying an additional 30 shares during the period. Goldman Sachs Group Inc. increased its position in Waters by 3.6% in the first quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock worth $73,733,000 after buying an additional 6,976 shares during the period. Empowered Funds LLC lifted its stake in Waters by 16.6% in the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock valued at $415,000 after buying an additional 160 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new position in shares of Waters during the second quarter valued at $232,000. 94.01% of the stock is owned by institutional investors.

Analysts Set New Price Targets

WAT has been the topic of several recent research reports. Rothschild & Co Redburn began coverage on shares of Waters in a research report on Wednesday, October 8th. They issued a “buy” rating and a $390.00 price objective on the stock. Guggenheim initiated coverage on shares of Waters in a research note on Tuesday, January 6th. They issued a “buy” rating and a $440.00 price target on the stock. Redburn Partners set a $390.00 price target on Waters in a report on Wednesday, October 8th. JPMorgan Chase & Co. increased their price objective on Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Finally, Morgan Stanley started coverage on Waters in a research report on Monday, December 1st. They issued an “equal weight” rating and a $423.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $395.00.

Waters Trading Up 1.0%

Shares of NYSE:WAT opened at $400.78 on Friday. The company has a 50 day moving average of $390.07 and a 200-day moving average of $341.65. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.41. The firm has a market cap of $23.87 billion, a P/E ratio of 36.84, a P/E/G ratio of 3.32 and a beta of 1.16. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56.

Waters (NYSE:WAT) last announced its earnings results on Tuesday, November 4th. The medical instruments supplier reported $3.40 EPS for the quarter, topping the consensus estimate of $3.21 by $0.19. The firm had revenue of $799.89 million for the quarter, compared to analysts’ expectations of $780.05 million. Waters had a return on equity of 36.59% and a net margin of 20.89%.The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.93 earnings per share. Waters has set its FY 2025 guidance at 13.050-13.150 EPS and its Q4 2025 guidance at 4.450-4.550 EPS. As a group, analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.